Advances in Tobacco Control

Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung Cancer Awareness Month, is a good time to highlight new advances in tobacco control, such as the legislation that came into effect Nov. 1, 2017, in New Jersey that raises the minimum age of legal access to tobacco products to 21.

Read More

FDA Approves Fourth ALK Inhibitor for Lung Cancer

Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the molecularly targeted therapeutic brigatinib (Alunbrig) for treating certain patients with metastatic non–small cell lung cancer (NSCLC).

Read More

From the Journals: High Glycemic Index Associated With Increased Risk of Lung Cancer

A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention found an association between glycemic index (a measure of carbohydrate intake and glucose levels) and increased lung cancer risk in non-Hispanic whites, particularly among those who never smoked.

Read More